Quest Diagnostics (DGX)
NASDAQ • Healthcare
January 21, 2026 at 19:16 UTC
Name
CEO
Website
Industry
Year Founded
Employees
Quest Diagnostics is a clinical laboratory company that turns biological samples into medical answers for physicians, hospitals, and health plans. Its role is straightforward: collect specimens, perform validated testing, and return clear reports that fit into everyday care. Digital ordering and result delivery reduce paperwork and keep data consistent across clinics and electronic records. The company also supports employers and public agencies with screening programs that follow the same chain-of-custody discipline. Operations extend across many regions, yet the promise is uniform — reliable turnaround, readable results, and service teams who understand how care is actually delivered. In health care, Quest Diagnostics serves as quiet infrastructure, helping clinicians confirm diagnoses, monitor therapy, and plan next steps with confidence.
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Quest Diagnostics's Technical Indicators Summary
DGX is exhibiting a generally bullish technical profile as the current price comfortably exceeds all major moving averages, including the 200-day SMA, signaling sustained upward momentum across short and long-term trends. Momentum indicators present a mixed but predominantly positive picture: the CCI is strongly bullish, and the MACD confirms upward momentum, while the RSI suggests the stock remains healthy without being overbought. The average true range indicates moderate volatility, supporting steady price movement without extreme swings. Although the ADX points to only moderate trend strength, the rising on-balance volume underscores growing buying interest. Overall, the technicals suggest DGX maintains a firm uptrend with healthy momentum and volume support.
| Indicator | Value |
|---|---|
RSI (14) | 66.08 |
Stochastic %K (14, 3, 3) | 95.56 |
CCI (20) | 240.83 |
WPR (14) | -7.57 |
Momentum (10) | 15.70 |
MFI | 60.37 |
MACD Level (12, 26) | 1.34 |
Bollinger Bands | $167.93 - $188.12 |
ATR (14) | $3.49 (1.84%) |
ADX (14) | 22.90 |
OBV | 14,203,700 |
Simple Moving Averages | $177.96 - $182.11(5 indicators) |
Exponential Moving Averages | $177.04 - $182.43(5 indicators) |
Get premium market insights delivered directly to your inbox.
DGX saw only a marginal positive bias at the bell, opening 0.037% above 188.95 at 189.02. From the opening stretch, DGX faces an extremely defensive options stance, with a high PCR of 2.23. DGX opens slightly higher amid a defensive options stance with limited immediate news impact.
Price Change
from $188.95 close
$-1.56
Trading Volume
Below avg (1.1M)
122.7K
vs S&P 500 Today
Underperforming Market
-2.42%
52-Week Position
Upper range
78.6%
Updated: January 21, 2026 at 15:36 UTC